First ever Pink Circle Award for $1million in breast cancer research
16 February 2010
The National Breast Cancer Foundation (NBCF) has awarded Sydney University's Associate Professor Sharon Kilbreath the Pink Circle Research award for exceeding the $1million mark in research funding.
"On behalf of the National Breast Cancer Foundation, I'm delighted to award our first-ever Pink Circles Research Award to Associate Professor Sharon Kilbreath, in recognition of her research funding exceeding $1 million," commented NBCF CEO, Sue Murray. "Her work in the areas of physical rehabilitation and lymphoedema are of real benefit to women who are undergoing treatment, and it's because of researchers like Sharon that I can proudly say that we are funding world class research in Australia."
The Pink Circle award comes on the back of Sharon's achievement of the NBCF Career Fellowship in 2009, which awarded her $1million over 5 years to pursue her work as Director of Sydney University's Breast Cancer Research Group.
The Group was established by Associate Professor Sharon Kilbreath in 2001 following her own battle with breast cancer. The Career Fellowship grant allows the group to further their research into identifying the specific causes and risk factors of long-term musculoskeletal problems suffered by many breast cancer survivors.
The Pink Circle was initially established by the NBCF to acknowledge companies and individuals whose investment in breast cancer research exceeded $1 million. Sharon's receipt of the Pink Circle Award at this year's NBCF Patron Awards makes her the first ever researcher to be recognised and puts her in the company of charitable organisations such as Foxtel, Hallmark, Mt Franklin and Pandora.
"I was very surprised and honoured to achieve this award," said Sharon. "It is testament not only to me but to my team! As mentioned by Sue Murray, our projects are aimed at minimising the long term impact of treatments on the breast cancer survivor. "
The Breast Cancer Research Group is currently looking to recruit women who have undergone breast cancer treatment for a range of studies including investigations around lymphoedema (swelling of the arm) and the effect of exercise on loss of bone density from aromatase inhibitors, a class of drugs used in the treatment of breast cancer.
For more information visit the Breast Cancer Research Group website.